ESC Premium Access

Translating GLP-1 trial outcomes to cardiology practice: which patients will benefit? .

Topic: Diabetes and the Heart
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Novo Nordisk

Congress Presentation

About the speaker

Professor Lars Ryden

Karolinska Institute, Stockholm (Sweden)
37 presentations
1 follower

4 more presentations in this session

Introduction - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?

Speaker: Professor T. Luscher (London, GB)

Thumbnail

Diabetes and cardiovascular disease: time for a multifactorial approach.

Speaker: Professor J. Deanfield (London, GB)

Thumbnail

GLP-1 receptor agonists: the cardiovascular benefits beyond glucose control.

Speaker: Professor F. Krag Knop (Copenhagen, DK)

Thumbnail

Discussion and summary - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?

Speaker: Professor T. Luscher (London, GB) Professor J. Deanfield (London, GB)

Thumbnail

Access the full session

Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice? (EBAC Accredited)

Speakers: Professor L. Ryden, Professor T. Luscher, Professor J. Deanfield, Professor F. Krag Knop, Professor T. Luscher...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by